Torregrosa C, Pernot S, Vaflard P, Perret A, et al. FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study. Int J Cancer 2022 Jun 15. doi: 10.1002/ijc.34166.
PMID: 35833561